Leslie S. Johnson
101Patents
20h-index
61Co-inventors
93Inventor score
Filing activity: Apr 7, 1998 → Aug 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7521542B2 | Humanized FcγRIIB-specific antibodies and methods of use thereof | Chemistry; Metallurgy | 64 | Expired |
| US9822181B2 | Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof | Chemistry; Metallurgy | 57 | Active |
| US7351803B2 | CD16A binding proteins and use for the treatment of immune disorders | Chemistry; Metallurgy | 57 | Expired |
| US7700100B2 | FcγRIIB fusion proteins and compositions thereof | Chemistry; Metallurgy | 49 | Active |
| US7700735B2 | High potency recombinant antibodies and method for producing them | Chemistry; Metallurgy | 47 | Expired |
| US7786270B2 | Humanized FcγRIIB-specific antibodies and methods of use thereof | Physics | 43 | Active |
| US8133982B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 43 | Active |
| US7112439B2 | Dual expression vector system for antibody expression in bacterial and mammalian cells | Chemistry; Metallurgy | 42 | Expired |
| US9096877B2 | Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use | Chemistry; Metallurgy | 40 | Active |
| US8216579B2 | Humanized FcγRIIB-specific antibodies and methods of use thereof | Physics | 39 | Active |
| US7553489B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 32 | Active |
| US9587021B2 | CD3-binding molecules capable of binding to human and non-human CD3 | Emerging Cross-Sectional Technologies | 27 | Active |
| US6833356B1 | Pneumococcal protein homologs and fragments for vaccines | Chemistry; Metallurgy | 26 | Expired |
| US8802091B2 | Antibodies reactive with B7-H3 and uses thereof | Chemistry; Metallurgy | 26 | Active |
| US7635568B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 26 | Expired |
| US9150656B2 | Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof | Chemistry; Metallurgy | 25 | Active |
| US7740851B2 | Ultra high affinity neutralizing antibodies | Chemistry; Metallurgy | 25 | Active |
| US7847082B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 23 | Active |
| US7618628B2 | CD16A binding proteins and use for the treatment of immune disorders | Chemistry; Metallurgy | 22 | Active |
| US9284375B2 | Covalent diabodies and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US8153133B2 | High potency recombinant antibodies and method for producing them | Chemistry; Metallurgy | 19 | Active |
| US8663634B2 | Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity | Chemistry; Metallurgy | 18 | Active |
| US8802093B2 | HER2/neu-specific antibodies and methods of using same | Chemistry; Metallurgy | 18 | Active |
| US8669349B2 | BCR-complex-specific antibodies and methods of using same | Chemistry; Metallurgy | 18 | Active |
| US7572456B2 | Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof | Emerging Cross-Sectional Technologies | 17 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.